POLASTMA - the Polish National Programme of Early Diagnosis and Therapy of Asthma

Authors: Kuna, P., Kupczyk, M., Kuprys-Lipinska, I.

Source: PNEUMONOLOGIA I ALERGOLOGIA POLSKA. 82(6):597-607

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN364016382&indx=1&recIds=ETOCRN364016382

Changes in the newest recommendations on Asthma Management and Prevention - GINA Report 2014. What should we pay attention to?

Authors: Kuprys-Lipinska, I., Kuna, P.

Source: PNEUMONOLOGIA I ALERGOLOGIA POLSKA. 82(5):393-401

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN360074789&indx=1&recIds=ETOCRN360074789

Impact of chronic obstructive pulmonary disease (COPD) on patient's life and his family

Authors: Kuprys-Lipinska, I., Kuna, P.

Source: PNEUMONOLOGIA I ALERGOLOGIA POLSKA. 82(2):82-95

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN350382239&indx=1&recIds=ETOCRN350382239

Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry power inhaler twice daily in patients with moderate asthma

Authors: Kuprys-Lipinska, I., Tworek, D., Vanderbist, F., Bochenska-Marciniak, M., Kuna, P.

Source: PNEUMONOLOGIA I ALERGOLOGIA POLSKA. 81(6):527-536

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN342580486&indx=1&recIds=ETOCRN342580486

Perennial is more effective than preseasonal subcutaneous immunotherapy in the treatment of seasonal allergic rhinoconjunctivitis

Authors: Tworek, D., Bochenska-Marciniak, M., Kuprys-Lipinska, I., Kupczyk, M., Kuna, P.

Source: AMERICAN JOURNAL OF RHINOLOGY AND ALLERGY. 27(4):304-308

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN337144080&indx=1&recIds=ETOCRN337144080

Two patterns of changes in nasal nitric oxide after lysine aspirin nasal challenge in patients with aspirin-exacerbated respiratory disease

Authors: Tworek, D., Kuprys-Lipinska, I., Pietruszewska, W., Kuna, P.

Source: AMERICAN JOURNAL OF RHINOLOGY AND ALLERGY. 26(6):428-432

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN324665454&indx=1&recIds=ETOCRN324665454

Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge

Authors: Kupczyk, M., Kurmanowska, Z., Kuprys-Lipinska, I., Bochenska-Marciniak, M., Kuna, P.

Source: RESPIRATORY MEDICINE. 104(10):1404-1409

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN277479253&indx=1&recIds=ETOCRN277479253

Acoustic rhinometry in the evaluation of intranasal aspirin challenge

Authors: Kupczyk, M., Kuprys-Lipinska, I., Bochenska-Marciniak, M., Kuna, P.

Source: PNEUMONOLOGIA I ALERGOLOGIA POLSKA. 78(2):103-111

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN269380250&indx=1&recIds=ETOCRN269380250

The underdiagnosis and undertreatment of asthma in general population of the Lodz Province (Poland)

Authors: Kuprys-Lipinska, I., Elgalal, A., Kuna, P.

Source: PNEUMONOLOGIA I ALERGOLOGIA POLSKA. :21-27

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN267514833&indx=1&recIds=ETOCRN267514833

Lipoxin A4 generation is decreased in aspirin-sensitive patients in lysine-aspirin nasal challenge in vivo model

Authors: Kupczyk, M., Antczak, A., Kuprys-Lipinska, I., Kuna, P.

Source: ALLERGY -COPENHAGEN-. 64(12):1746-1752

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN261044727&indx=1&recIds=ETOCRN261044727

Skin prick test with inhaled allergens in the general population of Lodz province

Authors: Kuprys-Lipinska, I., Elgalal, A., Kuna, P.

Source: PNEUMONOLOGIA I ALERGOLOGIA POLSKA. 77(3):229-234

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN255618737&indx=1&recIds=ETOCRN255618737

Epidemiology of atopic dermatitis in general population of Lodz province's citizens

Authors: Kuprys-Lipinska, I., Elgalal, A., Kuna, P.

Source: PNEUMONOLOGIA I ALERGOLOGIA POLSKA. :145-151

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN250239992&indx=1&recIds=ETOCRN250239992

Omalizumab, recombinant humanized monoclonal antibody anti-IgE - new fields of studies on the therapeutic indications

Authors: Kuprys-Lipinska, I., Kuna, P.

Source: PNEUMONOLOGIA I ALERGOLOGIA POLSKA. 77(1):43-51

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN247814186&indx=1&recIds=ETOCRN247814186

Budesonide/formoterol for maintenance and reliever therapy: new quality in asthma management

Authors: Kuna, P., Kuprys-Lipinska, I.

Source: THERAPY -LONDON-. 5(4):495-512

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN232650331&indx=1&recIds=ETOCRN232650331

Role of ciclesonide in asthma therapy

Authors: Kuprys-Lipinska, I., Kuna, P.

Source: PNEUMONOLOGIA I ALERGOLOGIA POLSKA. 76(1):37-43

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN225527621&indx=1&recIds=ETOCRN225527621

Hypereosinophilic syndrome with central nervous system involvement treated with anti-IL-5 therapy

Authors: Jonakowski, M., Kuprys-Lipinska, I., Lacwik, P., Stasiolek, M., Matysiak, M.

Source: In Multiple Sclerosis and Related Disorders June 2021 51

Safety of venom immunotherapy in patients pretreated with antihistamines - a retrospective study

Authors: Tworek, D., Bochenska-Marciniak, M., Kupczyk, M., Kuprys-Lipinska, I., Kuna, P.

Source: PNEUMONOLOGIA I ALERGOLOGIA POLSKA. 74(2):153-158

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN199255060&indx=1&recIds=ETOCRN199255060

Lipoxin A4 (LXA4) and Leukotriene C4 (LTC4) Levels in Nasal Lavages after Intranasal Provocation with Aspirin in Aspirin Sensitive and Aspirin Tolerant Patients

Authors: Kupczyk, M., Kuprys-Lipinska, I., Bochenska-Marciniak, M., Antczak, A., Gorski, P., Kuna, P.

Source: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 117(2):S144-S155

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN181675614&indx=1&recIds=ETOCRN181675614

The influence of mononucleosis infection on atopic disease development in children

Authors: Stanczyk-Przyluska, A., Szmidt, A., Kuna, P., Kuprys-Lipinska, I., Wolska, A.

Source: PNEUMOLOGIA I ALERGOLOGIA POLSKA. 73(1):18-22

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN180598088&indx=1&recIds=ETOCRN180598088

Statement of Expert Group of the Polish Society of Allergology on a therapeutic program of severe allergic asthma treatment with omalizumab

Authors: Bodzenta-Lukaszyk, A., Chazan, R., Fal, A., Kruszewski, J., Kuna, P., Kuprys-Lipinska, I., Nizankowka-Mogilnicka, E., Rogala, B.

Source: ALERGIA ASTMA IMMUNOLOGIA. 15(3):132-133

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN282891761&indx=1&recIds=ETOCRN282891761